发明名称 Method for treating psoriasis
摘要 Methods and kits for treating or preventing psoriasis or a symptom associated with psoriasis in a subject are described. The methods involve topical applications to the subject a therapeutically effective amount of an α2 adrenergic receptor agonist.
申请公布号 US9072739(B2) 申请公布日期 2015.07.07
申请号 US201313785802 申请日期 2013.03.05
申请人 Galderma Laboratories, L.P. 发明人 DeJovin Jack A.
分类号 A61K31/498;A61K31/417;A61K9/00;A61K9/06;A61K31/00;A61K31/135;A61K31/137;A61K31/4164;A61K47/02;A61K47/32 主分类号 A61K31/498
代理机构 Panitch Schwarze Belisario & Nadel LLP 代理人 Panitch Schwarze Belisario & Nadel LLP
主权项 1. A method of treating psoriasis or a symptom associated therewith in a subject in need thereof, the method comprising topically administering to a skin area of the subject a topical composition comprising a therapeutically effective amount of an alpha 2 adrenergic receptor agonist and a pharmaceutically acceptable carrier, wherein the skin area is, or is prone to be, affected by psoriasis or the symptom associated therewith, and the alpha 2 adrenergic receptor agonist is selected from the group consisting of (8-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine, (8-Bromo-quinoxalin-5-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine, (5-Bromo-3-methyl-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine, (5-Bromo-2-methoxy-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine, (4,5-dihydro-1H-imidazol-2-yl)-(8-methyl-quinoxalin-6-yl)-amine, and (4,5-dihydro-1H-imidazol-2-yl)-quinoxalin-5-yl-amine.
地址 Fort Worth TX US